LILRB1 and Miyoshi myopathy: LILRB1 blockade increased cytolysis of the Vγ9Vδ2 T-cell clone G42 and the SIL polyclonal Vγ9Vδ2 T-cell population against the MM cell line RPMI 8226 [34].